Modification of liposomal siRNA carriers with polyethylene glycol, i.e., PEGylation, is a generally accepted strategy for achieving in vivo stability and delivery to tumor tissue. However, PEGylation significantly inhibits both cellular uptake and the endosomal escape process of the carriers. In a previous study, we reported on the development of a multifunctional envelope-type nano device (MEND) for siRNA delivery and peptide-based functional devices for overcoming the limitations and succeeded in the efficient delivery of siRNA to tumors. In this study, we synthesized a pH-sensitive cationic lipid, YSK05, to overcome the limitations. The Collectively, these data confirm that YSK05 facilitates the endosomal escape of the MEND and thereby enhances the efficacy of siRNA delivery into cytosol and gene silencing.
Introduction
RNA interference (RNAi) can be used as novel therapeutic procedure through the specific in vivo silencing of therapeutically relevant target genes [1, 2] . Small interfering RNA (siRNA) duplexes are promising candidates for therapeutic molecules that might be capable of achieving the sequence-specific inhibition of objective genes such as for oncogenes in carcinomas. The most significant issue for bringing out the potency of siRNAs is an efficient delivery system, because the high molecular weight (~13 kDa) and negative charge of siRNA molecules are serious limitations to the passive diffusion across the plasma membrane of most cells and susceptibility to enzymatic degradation in an in vivo environment [3, 4] .
Therefore, although delivering siRNA without a carrier may be possible in some cases [5, 6] , systemic delivery to various tissues, including tumors, demands a carrier to stabilize and transport siRNA to the target cells.
Moreover, a carrier system is required, which can allow siRNA to avoid endosomal/lysosomal degradation and to be localized in the cytoplasm, where the RNAi machinery is located. Thus, a number of attempts to develop various nano carrier systems have been reported [7] [8] [9] [10] [11] [12] . We also recently reported on the development of a unique siRNA delivery system, described as a multifunctional envelope-type nano device (MEND) [13, 14] .
It is generally accepted that prolonging the circulation time of a nano carrier will facilitate tumoral accumulation via the enhanced permeability and retention (EPR) effect [15] . Sterically stabilization of a lipid based nano carrier by poly(ethyleneglycol) (PEG) is the most popular method and is widely used to enhance circulation time by reducing nonspecific interaction between positively charged nano carriers and negatively charged serum components, leading to severe aggregation and rapid clearance from circulation by the reticuloendothelial system [16] . However, it is well-known that PEGylation leads to a severe decline of cellular uptake via endocytosis and the endosomal escape process of nano carriers, which results in the loss of efficacy for delivering siRNA into the cytoplasm [17, 18] . In other words, PEGylation improves the pharmacokinetics but decreases the intracellular trafficking of the nanocarrier, a situation that we refer to as the 'PEG-dilemma' [19] .
To resolve the PEG-dilemma, many groups have attempted to use functional devices, such as a cleavable PEG-lipid that is affected by an acidic or reducing condition [20, 21] . We previously reported on the production of a functional PEG-lipid, PPD, that is affected by matrix metalloproteinases (MMPs), which are secreted by various tumor cells and succeeded in silencing marker gene expression in tumor tissue by the systemic administration of PPD modified MEND [22, 23] . In addition, we reported that GALA, a pH-sensitive fusogenic peptide, modified MEND could be applied to an in vivo intratumoral injection model and shGALA, a new shorter version of GALA to improve the pharmacokinetics of the MEND, which was modified to achieve gene silencing in tumor tissue followed by systemic administration [23] [24] [25] [26] . As other strategy, Semple S.C. et. al. [27] reported that the pharmacokinetics of the lipid nanoparticles (LNPs) with an ionizable aminolipid, which is largely neutral but changes to a cationic form under acidic conditions, was improved compared to that with a conventional cationic lipid. The LNPs system also succeeded in tumor specific reporter gene expression, and gene silencing in orthotopic and subcutaneous tumors [28, 29] .
In the present study, we report on the development of a new pH-sensitive cationic lipid, YSK05, for improving the efficient intracellular trafficking and consequently to improve the gene silencing activity of a MEND both in vitro and in vivo instead of peptide-based functional devices (PPD, GALA and shGALA). Our results suggest that by the suitable manipulation of intracellular trafficking, the successful delivery of siRNA can be achieved, both in vitro and in vivo. 6 
Materials and Methods

Materials
Anti-luciferase siRNA (sense: 5'-CCG UCG UAU UCG UGA GCA AdTdT-3'; antisense: 5'-UUG CUC ACG AAU ACG ACG GdTdT-3') was purchased from Sigma (Ishikari, Japan). Anti-PLK1 siRNA (sense: 5'-AGA uCA CCC uCC UUA AAu AUU-3'; antisense: 5'-UAU UUA AGG AGG GUG AuC UUU-3', 2'-OMe-modified nucleotides are in lowercase.) and Cy5-labeled anti-luciferase siRNA (sense: 5'-Cy5-GCG CUG CUG GUG CCA ACC CdTdT-3'; antisense: 5'-GGG UUG GCA CCA GCA GCA GCC CdTdT-3') were purchased from Hokkaido System Science Co., Ltd. (Sapporo, Japan).
Protamine was purchased from CalbioChem (San Diego, CA, USA). human renal cell carcinoma cells were kindly provided by K. Hida (Hokkaido University, Sapporo, Hokkaido, Japan).
Experimental animals
Male ICR mice and BALB/cAjcl nude mice were purchased from Japan SLC (Shizuoka, Japan) and CLEA (Tokyo, Japan), respectively. The experimental protocols were reviewed and approved by the Hokkaido University Animal Care Committee in accordance with the guidelines for the care and use of laboratory animals.
MEND formulations
All MENDs were prepared using a cationic lipid, a phospholipid, cholesterol and PEG-DMG using a t-BuOH dilution procedure. The initial MENDs had a component molar ratio of 30/40/30/3 (DOTAP, DODAP or YSK05/DOPE/cholesterol/PEG-DMG) and optimized YSK05 MEND had 50/25/25/3 (YSK05/POPE/cholesterol/PEG-DMG). PEG-DMG was used to stabilize the lipid membrane during the formulation process and for preservation. Typically, 1.5 mM lipids were dissolved in 90% t-BuOH solution. siRNA was complexed with protamine at a nitrogen/phosphate ratio of 1.1 in 1 mM citrate buffer (pH4.5) and was titrated slowly to lipid solution under vigorous mixing to avoid low local concentration of t-BuOH and diluted quickly with citrate buffer to final <20% t-BuOH. Ultrafiltration was performed to remove t-BuOH, replacing external buffer with phosphate buffered saline (PBS, pH7.4) and concentrating the MENDs. To incorporate PEG-DSG, the MENDs were incubated at 45 0 C for 45 minutes with PEG-DSG at 5.0 mol% total lipid under 10 v/v% ethanol conditions. Again, ultrafiltration was performed against PBS to remove EtOH and for concentration. An empty MEND with the same lipid composition was prepared by a similar procedure, with the exception that an equivalent volume of 1 mM citrate buffer was titrated to the lipid solution instead of siRNA/protamine complex. Radiolabeled MENDs were prepared by adding a trace amount of 3 H-CHE to the lipid-t-BuOH solution prior to mixing with the siRNA/protamine complex. The average diameter and zeta-potential of MENDs were determined using a Zetasizer Nano ZS ZEN3600 (MALVERN Instrument, Worchestershire, UK).
Ribogreen assay
To determine siRNA encapsulation efficiency and its concentration, Ribogreen fluorescence assay was performed. MENDs were diluted in 10 mM hepes buffer at pH7.4 containing 20 g/mL dextran sulfate and Ribogreen in the presence or absence of 0.1 w/v% TritonX-100. Fluorescence was measured by Varioskan Flash (Thermo scientific) with ex=500 nm, em=525 nm. siRNA concentration was calculated from siRNA standard curve. siRNA encapsulation efficiency was calculated by comparing siRNA concentration in the presence and absence of TritonX-100.
TNS assay
Thirty M of MEND lipid and 6 M of TNS were mixed in 200 L of 20 mM citrate buffer, 20 mM sodium phosphate buffer or 20 mM Tris-HCl buffer, containing 130 mM NaCl, at a pH ranging from 3.0 to 9.0. Fluorescence was measured by a Varioskan Flash set up with ex=321 nm, em=447 nm at 37 0 C. The pKa values were measured as the pH giving rise to half-maximal fluorescent intensity.
Stability of MENDs in mouse serum
Fresh mouse serum was collected from a male ICR mouse and mixed with free siRNA, a mixture of siRNA/protamine complex and the empty MEND, and MEND formulating siRNA followed by incubation at 37 0 C for various periods. For disruption of the lipid bilayer of the MEND, 0.05 w/v% TritonX-100 was added to incubation mixture. At selected time points, aliquots were frozen at -80 0 C to stop siRNA degradation. Afterward, the samples were thawed at r.t. and siRNA was immediately extracted with a phenol-chloroform-isoamylalcohol mixture. The aqueous phase, containing the siRNA, was run on 20% polyacrylamide gels. After 2 hours of electrophoresis at 150 V, siRNA was stained and visualized with 1 g/mL ethidium bromide. Firefly and Renilla luciferase activities were analyzed using the Dual-Glo assay (Promega) according to manufacture protocol. Luminescence was measured using a luminometer (Luminescencer-PSN, ATTO, Japan). For data analysis, Firefly luciferase activity was normalized by Renilla luciferase activity and treated samples were compared to untreated samples to determine degree of luciferase silencing.
Cellular uptake
Twenty-four hours prior to transfection, HeLa-dluc cells were seeded at a density of 1 x 10 5 cells per well in 6-well plates in growth medium and incubated overnight at 37 0 C in 5% CO2 to allow cells attachment. Radioactivity was determined using a LSC-6100 (ALOKA) scintillation counter. The amount of cellular uptake was represented as the % of total transfected radioactivity.
Hemolysis assay
Fresh red blood cells (RBC) were collected from an ICR mouse and suspended in PBS. The RBC suspension was mixed with each quantity of empty MEND, and incubated at 37 0 C for 30 minutes. After the incubation, the absorbance at 545 nm of supernatant was measured after centrifugation RNA ligation was performed at 37 0 C for 1 hour in 1 x ligation buffer, T4 RNA ligase (TaKaRa, Japan) and 1.2 g RNA adaptor (5'-NH2-CGA CUG GAG CAC GAG GAC ACU GAC AUG GAC UGA AGG AGU AGA AA-3'). Samples were then purified by phenol-chloroform-isoamylalcohol extraction and ethanol precipitation. The RNA ligation product (10 L) was reverse transcribed using SuperScript III (Invitrogen) and PLK1 gene specific primer (5'-GGA CAA GGC TGT AGA ACC CAC AC-3'). After heat denaturalization at 65 0 C for 5 minutes followed by snap cooling at 4 0 C, reverse transcription was carried out at 50 0 C for 1 hour followed by inactivation at 70 0 C for 15 minutes and snap-cooling at 4 0 C. 5' RACE PCR was performed using forward primer (Ad1) in the RNA adaptor and reverse primer (Rev1) in the 3' end of PLK1 mRNA. PCR primer sequences were Ad1 5'-CGA CTG GAG CAC GAG GAC ACT GA-3' and Rev1 5'-GCT TGT CCA CCA TAG TGC GG-3'. PCR was performed using a 2720 Thermal Cycler 
Synthesis of YSK05
DOTAP and DODAP are commercially available cationic lipids for transfection. The former is a quaternary ammonium derivative, resulting in cationic properties that are independent of the pH environment (Fig. 1) . In contrast, the latter has a structure similar to DOTAP except that it contains a tertiary amine instead of a quaternary ammonium group resulting in pH-sensitive properties and becomes cationic at an acidic pH and is almost neutral at physiological pH. It is known that unsaturated carbon chains cause the formation of cone shaped molecules which promote transfection efficiency through facilitating the process of endosomal escape. Attempts to design new lipid structures based on this well known knowledge and in consideration of the ease of synthesis resulted in the successful synthesis of YSK05 as described. YSK05, newly synthesized in this laboratory, also contains one tertiary amine which confers pH-sensitive properties, and long, unsaturated carbon chains for emphasizing a cone shaped structure (Fig.1) .
The yield was 62% (Supplementary methods).
Fig. 1. Chemical structures of cationic lipids incorporated into MENDs
DOTAP and DODAP are conventional and available cationic lipids which have quaternary ammonium, indicating cationic without depending on pH, and tertiary amine, indicating cationic at acidic pH and neutral at physiological pH, respectively. YSK05 is a cationic lipid that contains a tertiary amine group for pH-sensitivity.
Characteristics of the prepared MENDs
To prepare small and uniform particles and efficiently encapsulate siRNA reproducibly, MENDs were formulated by a t-BuOH dilution process as described. Particle size, zeta-potential, siRNA encapsulation and apparent pKa were assessed and the data are shown in Table 1 Fig. S1 ).
Table 1. Physical properties of MENDs
Particle diameter, polydispersity and zeta-potential were measured using a Malvern Zetasizer. Percentage of siRNA encapsulation was determined by Ribogreen fluorescence assay to measure the amount of siRNA relative to total siRNA present. Apparent pKa value was determined by TNS fluorescence assay as a pH giving rise to half-maximal fluorescent intensity. Data points are expressed as the mean ± SD (n=3). (that is, the dose to achieve 50% gene silencing) was around 30 nM, while DODAP-MEND failed to induce clear gene silencing (Fig. 2a) . The amount of cellular uptake of each formulation was next measured with MENDs with incorporated 3 H-labeled CHE (Fig. 2b) . The cellular uptake of the MEND containing DOTAP, pH-insensitive cationic lipid, was highest, while that of MENDs containing each pH-sensitive cationic lipid, almost neutral at physiological pH, were relatively low and similar to one another. The ability of MENDs to induce membrane disruption with RBC membranes was evaluated to judge the potency for escape from the endosomal compartment via membrane fusion. As shown in Fig. 2c , it was observed that YSK05-MEND induced membrane disruption depending on the dose of MENDs and decline of pH, while other two MENDs induced only minor membrane disruption even at low pH. 
Optimization of YSK05-MEND lipid composition
To enhance the potency of the YSK05-MEND, the influence of phospholipid on gene silencing activity was evaluated. We used three phosphatidyl choline and two phosphatidyl ethanolamine derivatives as candidate phospholipids.
It was observed that the YSK05-MEND containing any phosphatidyl choline (PC) failed to induce high gene silencing activity, while phosphatidyl ethanolamine (PE) succeeded ( Supplementary Fig. S2 ). Additionally, we found that YSK05-MEND containing POPE had a higher gene silencing potency than DOPE and the highest stability in mouse serum of all tested phospholipids. Moreover, we found the optimal ratio of lipid combination (Table 1 ) and the IC50 of 2 nM, approximately 15 times lower than unoptimized one (Fig.   3a) . The cellular uptake of optimized YSK05-MEND was almost similar to that for the unoptimized one (Fig. 3b) , while the hemolytic activity of the former was significantly higher than the latter (Fig. 3c) . Namely, it was revealed that the escalation of gene silencing activity through the optimization resulted from the escalation of the endosomal escape ability but not cellular uptake. We also evaluated the durability of gene silencing of the optimized YSK05-MEND (Supplementary Fig. S4 ). The findings indicate that the durability of gene silencing was dependent on the dose of siRNA, and the gene silencing rate decreased to 50% or below on day 4 at a dose of 10 nM siRNA and on day 7 at a dose of 100 nM siRNA. Data points are represented as the mean ± SD. N.C.; negative control.
YSK05-MEND internalizes via endocytosis and escapes depends on endosomal acidification
To further investigate the intracellular fate of siRNA formulated in the YSK05-MEND, Cy5-labeled siRNA was encapsulated in DODAP-MENDs and optimized YSK05-MENDs and observed in HeLa-dluc cells using confocal microscope (Fig. 4a and Supplementary Fig. S3 ). Most of the Cy5 fluorescence of both formulations exhibited a punctuate pattern at the 0 hour time point, suggesting that both formulations were internalized into cells via endocytosis (Fig. 4a, upper) . However, at the 6 hour time point, a formulation dependent difference was observed in the intracellular distribution pattern of Cy5-labeled siRNA in HeLa-dluc cells (Fig. 4a, lower) . Cy5-labeled siRNA formulated in DODAP-MENDs exhibited a punctuate pattern at the 6 hour time point, the same as the 0 hour time point. In contrast, most Cy5-labeled siRNA formulated in optimized YSK05-MENDs exhibited a diffuse distribution at the 6 hour time point. This result suggests that the optimized YSK05-MEND delivered siRNA into the cytoplasm through escaping lysosomal degradation following internalization via endocytosis. To confirm that the release of siRNA in the cytoplasm by the YSK05-MEND was dependent on endosomal acidification, the gene silencing activity of the optimized YSK05-MEND was evaluated in the presence of an inhibitor of endosomal acidification (Fig. 4b) . Two low molecular weight drugs, chloroquine and ammonium chloride (NH4Cl), were used for buffering acidic vesicles, resulting in the inhibition of lysosomal enzymes and possibly altering normal lysosomal trafficking. DOTAP-MEND was used as a control of pH-independent carrier. The gene silencing activity of DOTAP-MEND slightly increased depending on drug concentration, while that of YSK05-MEND was significantly suppressed by both drugs. From these results, it was confirmed that optimized YSK05-MEND was taken up into cells via endocytosis and escaped from endosome significantly depending on endosomal acidification followed by inducing gene silencing. 
PEGylated optimized YSK05-MEND induces gene silencing both in vitro and in vivo
The incorporation of PEG-DSG into optimized YSK05-MENDs was carried out to provide stability under an in vivo environment. It is known that PEG lipid with a long acyl chain, such as PEG-DSG, is retained strongly by a lipid membrane while PEG lipid with short acyl chain, such as PEG-DMG, dissociated more readily from a membrane [28] . After the incorporation of PEG-DSG, the stability of the optimized YSK05-MEND in serum was significantly increased, as expected ( Supplementary Fig. S7) (Fig. 5c) . To confirm that the gene silencing was clearly the result of RNAi, we detected the RNAi-specific PLK1 mRNA cleavage product by the 5' RACE PCR method. Active PLK1 mRNA cleavage was detected only after administration of siPLK1 formulated in optimized YSK05-MEND but not the non-treatment control or the anti-luciferase siRNA (siGL4) control, clearly demonstrating that a sequence specific RNAi occurred in tumor tissues (Fig. 5d) . 
Discussion
There are several obstacles to the delivery of siRNA. These include its safe delivery to the target cell population, internalization into the cells and escape from the endosomal compartment for protecting from lysosomal degradation and localization in the cytoplasm, where siRNAs located and functions. PEGylation enhances the stability and half-life of nano carriers in blood circulation by avoiding recognition and clearance by phagocytic cells of the reticuloendothelial system and is widely used in in vivo applications of nano carriers. As the conventional MEND was composed of a cationic lipid, such as DOTAP, it was necessary to modify the conventional cationic MEND with high amounts of PEG lipids to suppress non-specific electrostatic interactions with internal components, such as negatively charged proteins [22, 23, 26] . However, it is also known that PEGylation results in a significant loss of gene silencing efficiency. We previously showed that the two intracellular processes, cellular uptake and endosomal escape, are suppressed by PEGylation. The outer PEG layer sterically hinders interaction between a carrier and cell surface membrane, and results in a decrease in cellular uptake via endocytosis. After uptake, the PEG layer similarly inhibits endosomal escape via membrane fusion between the carrier membrane and the endosomal membrane. In order to solve this problem, it is necessary to remove or reduce the level of the PEG moiety.
Strategies for overcoming the PEG-dilemma are outlined below. The first is acceleration of steps that are inhibited, such as cellular uptake and endosomal escape, by introducing functional devices into highly PEG-modified carriers. As shown previously, more than 10 mol% of PEG is necessary to achieve sufficient blood circulation in the case of a cationic DOTAP-MEND [22] . Therefore, the highly PEGylated DOTAP-MEND was modified with enzymatically cleavable PEG [23] or a shorter version the GALA peptide [26] to achieve both sufficient blood circulation and efficient silencing activity. The second approach is decreasing the level of the PEG moiety by introducing charge changeable devices. Huang L and colleagues [30] proposed the concept of pH-sensitive liposomes, that release encapsulated drugs following an acid treatment. Judge AD and colleagues [31] prepared stable nucleic acid lipid particles (SNALP) and succeeded in achieving gene silencing in tumor tissue after the systemic administration of low amounts of PEG lipid used in the modification process. SNALP is comprised of an ionizable amino lipid and it was reported that the chemical structure of the ionizable amino lipid has a significant influence on the intracellular fate of SNALP [32, 33] . In this study, we synthesized a new pH-sensitive cationic lipid, YSK05, for the second purpose.
YSK05-MEND induced higher gene silencing activity than other MENDs containing each conventional cationic lipid, DOTAP and DODAP, a pH-insensitive and a pH-sensitive cationic lipid, respectively (Fig. 2) . Despite its comparable cellular uptake, the YSK05-MEND showed a significantly higher gene silencing activity than DODAP-MEND. There are two reasons for this, described below. One reason is that the YSK05-MEND with an apparent pKa of around 6.6, can rapidly become a cationic species in response to endosomal acidification and thus avoid lysosomal degradation, while the DODAP-MEND with an apparent pKa < 6.0, cannot accomplish this, at least not rapidly ( Table 1) . The other reason is that YSK05-MEND has a considerably higher hemolytic activity than the DODAP-MEND, indicating that YSK05-MEND can more easily escape from endosomes via membrane fusion (Fig. 2c) . It was verified, using confocal microscopy, that YSK05-MEND escapes from endosomes followed by releasing siRNA into cytosol (Fig. 4a) . Also, the YSK05-MEND indicated higher gene silencing activity than DOTAP-MEND in spite of the fact that the amount of cellular uptake of the former was lower than that of the latter (Fig. 2a and c) . This result also can be explained from the observation that the YSK05-MEND has a significantly higher potency for membrane fusion than the DOTAP-MEND, as evidenced by a hemolysis assay (Fig. 2c) .
Additionally, the lipid composition significantly influenced the gene silencing activity of YSK05-MEND. YSK05-MENDs containing two phosphatidyl ethanolamines, DOPE and POPE, induced gene silencing at a dose of 9 nM, while the YSK05-MENDs containing all of the phosphatidyl cholines failed (Supplementary Fig. S2b ). The cause of this result might be the shape of the phospholipid molecules. It is generally accepted that phosphatidyl ethanolamine is classified as an inverted lipid capable accelerating membrane fusion by inducing structural changes in the lipid membrane from a lamellar to a inverted hexagonal (HII) phase, while phosphatidyl choline induced the formation of a cylindrical lipid capable stabilizing a lamellar phase [34] . Although there is no direct evidence to show that the YSK05-MEND containing POPE has a higher gene silencing activity than DOPE, the excellent stability in serum of the former may account for this ( Supplementary Fig. S2a ). We next, carried out the screening of lipid composition of YSK05-MEND, containing YSK05, POPE and cholesterol, and represented the resulting MEND as the optimized YSK05-MEND. The physical parameters of the optimized YSK05-MEND were similar to the unoptimized preparation. The potential for endosomal escape but not cellular uptake was enhanced through optimization of the lipid components and resulted in the escalation of gene silencing activity (Fig.   3 ). We then evaluated the durability of gene silencing of the optimized YSK05-MEND using HeLa-dluc cells. The durability of gene silencing was extended by increasing the dose of siRNA from 10 nM to 100 nM. This result would result from a situation where the excess siRNAs in the cytosol were incorporated into the RNA-induced silencing complex (RISC) one after another following the degradation of siRNAs incorporated into RISC.
Although the durability of gene silencing is dependent on the cell division rate, the stability of siRNA and so on, the span and pattern was similar to thatreported in our previous study [34] .
The result of confocal microscopy experiments confirmed that the optimized YSK05-MENDs were taken up via endocytosis and were able to release siRNA into the cytoplasm by endosomal escape after a 6 hour chase (Fig. 4a) . In contrast, siRNA formulated in the DODAP-MEND showed a punctuate pattern even in the case of a 6 hour chase, indicating that the DODAP-MEND failed to escape from the endosomal compartments. This result corresponds to the failure of both gene silencing and hemolysis. To elucidate the dependence on pH decline for endosomal escape and further gene silencing of the YSK05-MEND, transfection in the presence of chloroquine and NH4Cl was examined. Chloroquine and NH4Cl are known to buffer the pH of endosomes and lysosomes and to improve the transfection efficiency of vectors which are unable to escape from the lysosomal trafficking pathway [36] [37] [38] [39] . The gene silencing activity of DOTAP-MEND, a pH-insensitive carrier, gradually increased depending on the concentration of each compound, indicating that the endosomal escape efficacy of the DOTAP-MEND was increased by avoiding trafficking to degradative lysosomes. In contrast, the gene silencing activity of the optimized YSK05-MEND dramatically decreased, indicating that the endosomal escape process of the YSK05-MEND strongly depends on the acidification of endosomes as we expected (Fig. 4b) .
Finally, we evaluated the gene silencing activity of the MENDs in tumor tissue. In this study, we chose the amount of PEG modification as 5 mol% of the total lipid, because the blood circulation of DODAP-MEND with 3.5 or more mol% of PEG was saturated, indicating that a 5 mol% PEG modification is sufficient in terms of preventing nonspecific interactions between DODAP-MEND, a pH-sensitive cationic system, and serum components ( Supplementary Fig. S5 ). Actually, an attempt to induce gene Another possibility is that the optimized YSK05-MEND was taken up by other cells in tumor tissue, such as tumor associated macrophages, rather than tumor cells. Therefore, the surface of the MEND would have been shielded by the incorporation of PEG-DSG, increasing its physical stability and reducing non-specific cellular uptake. In an in vitro examination, the cellular uptake of the optimized YSK05-MEND with 5 mol% of PEG-DSG incorporated was severely reduced (Fig. 5a ). This indicates that 5 mol% PEG modification is sufficient to prevent nonspecific interaction between the optimized YSK05-MEND and biomembranes at physiological pH. However, the gene silencing activity of the optimized YSK05-MEND with PEG-DSG incorporated was similar to that for LF2k, a commonly used transfection reagent (Fig. 5b) , indicating that it escaped efficiently from endosomes. This result can be explained as follows. DOTAP-MEND, a cationic system, could be shielded by the 5 mol% PEG and more than 10 mol% PEG was necessary for shielding its surface sufficiently ( Supplementary Fig. S5 ), indicating that 5 mol% PEG was not sufficient to shield the highly cationic surface of the MEND. Once the optimized YSK05-MEND is internalized via endocytosis, YSK05 (50 mol% of total lipid) was immediately protonated in the acidified interior of the endosome. Therefore, only 5 mol% PEG could not sufficiently prevent the interaction between the protonated (cationic) YSK05 of the MEND lipid bilayer and anionic lipids of the endosomal membrane, resulting in efficient endosomal escape. This suggests that YSK05 is sufficiently potent to permit it to overcome the PEG dilemma, compared to the use of PPD and GALA, as we previously reported [21, 22, 24] . PEG-DSG incorporated MENDs containing various lipid compositions were topically administrated on OS-RC-2 subcutaneous tumors and the gene silencing activity of each MEND was evaluated in vivo. Only the MEND containing YSK05 was able to induce gene silencing, indicating that YSK05 is also able to overcome the PEG dilemma in vivo, as well (Fig. 5c) Fig. S7 ). The findings revealed that gene silencing by the optimized YSK05-MEND was induced more easily in OS-RC-2 cells than in HeLa-dluc cells (Supplementary Fig. S7a ). However, cytotoxicity as the result of PLK1 silencing was not observed on OS-RC-2 cells, but was clearly observed in HeLa-dluc cells ( Supplementary Fig. S7b,   c ). These findings, therefore, suggest that PLK1 gene silencing on OS-RC-2 subcutaneous tumor tissue by the topical administration of optimized YSK05-MEND would fail to induce an antitumor effect. To obtain an antitumor effect, it will be necessary to examine other target genes that are capable inducing apoptosis or suppressing the cell proliferation of OS-RC-2 cells through its gene silencing.
Conclusion
The results of present study indicate that the new pH-sensitive cationic lipid YSK05 improves the intracellular trafficking of non-viral vectors. In an in vitro study, the gene silencing efficiency of YSK05-MEND was significantly greater than that of DOTAP-and DODAP-MENDs. It was confirmed that YSK05-MEND efficiently escaped from endosomes and the process was strongly dependent on endosomal acidification. Furthermore, the PEG-DSG incorporated optimized YSK05-MEND showed a gene silencing activity that was similar to LF2k, suggesting that YSK05 overcame the suppression of endosomal escape by PEGylation. In the in vivo study, the optimized YSK05-MEND indicated most efficient gene silencing of all MENDs and RNAi mediated gene silencing was confirmed by the detection of sequence specific mRNA cleavage products using the 5' RACE PCR method.
Collectively, YSK05 effectively enhances siRNA delivery both in vitro and in vivo. Ribogreen fluorescence assay to measure the amount of siRNA relative to total siRNA present. Apparent pKa value was determined by TNS fluorescence assay as a pH giving rise to half-maximal fluorescent intensity. Data points are expressed as the mean ± SD (n=3). 
